State Street’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

State Street’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,434,601	Closed	-$94.6M	–	4730
2021 Q2	$94.6M	Buy	3,434,601 +137,767	+4%	+$2.71M	0.01%	1342
2021 Q1	$54.4M	Buy	3,296,834 +209,158	+7%	+$4.77M	﹤0.01%	1684
2020 Q4	$56.9M	Sell	3,087,676 -1,968,941	-39%	-$35.2M	﹤0.01%	1561
2020 Q3	$68.8M	Buy	5,056,617 +3,143,336	+164%	+$48.5M	﹤0.01%	1217
2020 Q2	$34.3M	Buy	1,913,281 +1,200,174	+168%	+$18.1M	﹤0.01%	1689
2020 Q1	$7.11M	Buy	713,107 +92,770	+15%	+$760K	﹤0.01%	2462
2019 Q4	$5.05M	Buy	620,337 +57,280	+10%	+$529K	﹤0.01%	2847
2019 Q3	$5.58M	Buy	563,057 +63,425	+13%	+$599K	﹤0.01%	2729
2019 Q2	$6.31M	Buy	499,632 +186,982	+60%	+$1.97M	﹤0.01%	2708
2019 Q1	$3.19M	Buy	312,650 +171,411	+121%	+$1.31M	﹤0.01%	2970
2018 Q4	$1.06M	Buy	141,239 +56,139	+66%	+$411K	﹤0.01%	3316
2018 Q3	$851K	Buy	+85,100	New	+$991K	﹤0.01%	3425

State Street's TBIO Position: Q3 2021 in Review

State Street sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 3,434,601 shares — an estimated $94.6M sold.

State Street first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $94.6M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

State Street reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
State Street sold 3,434,601 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $94.6M.
State Street first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
State Street's Translate Bio, Inc. Common Stock position peaked at $94.6M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on State Street's 13F filing for Q3 2021, filed 15 Nov 2021.